STOCK TITAN

Teva Pharmaceutical Industries (TEVJF) Stock Price, News & Analysis

TEVJF OTC Link

Company Description

Teva Pharmaceutical Industries (OTC Link: TEVJF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $33.1B.

TEVJF has gained 59.5% over the past year. Shares last traded at $28.40.

For FY2025, Teva Pharmaceutical Industries reported revenue of $17.3B with net income of $1.4B and diluted earnings per share of $1.21. The company operates at a net profit margin of 8.2%.

This page collects what Stock Titan holds for TEVJF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
+59.5%
Performance 1 year
$33.1B

Teva Pharmaceutical Industries (TEVJF) stock last closed at $28.40. Over the past 12 months, the stock has gained 59.5%. At a market capitalization of $33.1B, TEVJF is classified as a large-cap stock with approximately 1.2B shares outstanding.

See what a $1,000 investment in TEVJF would be worth today

TEVJF Rankings

Latest News

No recent news available for TEVJF.

SEC Filings

Teva Pharmaceutical Industries has filed 5 recent SEC filings, including 2 Form 4, 1 Form 144, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on July 29, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TEVJF SEC filings →

Financial Highlights

Teva Pharmaceutical Industries generated $17.3B in revenue in FY2025, retaining a 51.8% gross margin, operating income reached $2.2B (12.5% operating margin), and net income was $1.4B, reflecting a 8.2% net profit margin. Diluted earnings per share stood at $1.21. The company generated $1.6B in operating cash flow. With a current ratio of 1.04, the company maintains adequate short-term liquidity.

$17.3B
Revenue (FY2025)
$1.4B
Net Income (FY2025)
$1.6B
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Teva Pharmaceutical Industries (TEVJF) currently stands at 238.4 thousand shares, representing 0.0% of the float. Since August 2025, short interest has decreased by 87.2%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Teva Pharmaceutical Industries (TEVJF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.

TEVJF Company Profile & Sector Positioning

Teva Pharmaceutical Industries (TEVJF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.

Frequently Asked Questions

What is the current stock price of Teva Pharmaceutical Industries (TEVJF)?

The current stock price of Teva Pharmaceutical Industries (TEVJF) is $28.4 as of July 21, 2026.

What is the market cap of Teva Pharmaceutical Industries (TEVJF)?

The market cap of Teva Pharmaceutical Industries (TEVJF) is approximately 33.1B. Learn more about what market capitalization means .

What is the revenue of Teva Pharmaceutical Industries (TEVJF) stock?

The FY2025 revenue of Teva Pharmaceutical Industries (TEVJF) is $17.3B, from its most recent completed fiscal year.

What is the net income of Teva Pharmaceutical Industries (TEVJF)?

The FY2025 net income of Teva Pharmaceutical Industries (TEVJF) is $1.4B, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Teva Pharmaceutical Industries (TEVJF)?

The diluted earnings per share (EPS) of Teva Pharmaceutical Industries (TEVJF) is $1.21 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Teva Pharmaceutical Industries (TEVJF)?

The operating cash flow of Teva Pharmaceutical Industries (TEVJF) is $1.6B. Learn about cash flow.

What is the profit margin of Teva Pharmaceutical Industries (TEVJF)?

The net profit margin of Teva Pharmaceutical Industries (TEVJF) is 8.2%. Learn about profit margins.

What is the operating margin of Teva Pharmaceutical Industries (TEVJF)?

The operating profit margin of Teva Pharmaceutical Industries (TEVJF) is 12.5%. Learn about operating margins.

What is the gross margin of Teva Pharmaceutical Industries (TEVJF)?

The gross profit margin of Teva Pharmaceutical Industries (TEVJF) is 51.8%. Learn about gross margins.

What is the current ratio of Teva Pharmaceutical Industries (TEVJF)?

The current ratio of Teva Pharmaceutical Industries (TEVJF) is 1.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Teva Pharmaceutical Industries (TEVJF)?

The gross profit of Teva Pharmaceutical Industries (TEVJF) is $8.9B for FY2025, its most recent completed fiscal year.

What is the operating income of Teva Pharmaceutical Industries (TEVJF)?

The operating income of Teva Pharmaceutical Industries (TEVJF) is $2.2B. Learn about operating income.